Methadone is a full opioid agonist, meaning it activates the same brain receptors as heroin, morphine, and fentanyl. It is physically addictive. Your body will develop dependence on it within weeks, and stopping abruptly causes withdrawal. But “how addictive” depends on context: methadone taken under medical supervision for opioid use disorder carries a very different risk profile than methadone obtained and used without a prescription.
How Methadone Works in the Brain
Methadone binds strongly and selectively to mu-opioid receptors, the same targets that make heroin and prescription painkillers both effective and dangerous. Its binding affinity for those receptors is high, and it is far more selective for mu receptors than for the other two opioid receptor types (kappa and delta). This selectivity is what makes it useful for treating opioid addiction: it occupies the receptors steadily, reducing cravings and blocking the intense highs from other opioids.
The key difference between methadone and faster-acting opioids is speed. Drugs like heroin and fentanyl flood the brain quickly, creating a sharp spike of pleasure that the brain learns to chase. Methadone is absorbed and released more slowly, producing a stable, even effect rather than a rush. That slow onset makes it less reinforcing psychologically, even though it acts on the same receptors. It still produces warmth, pain relief, and mild sedation, but the experience is more like a plateau than a peak.
Physical Dependence vs. Addiction
This distinction matters more with methadone than almost any other drug. Physical dependence means your body has adapted to the presence of the drug and will react when it’s removed. Addiction, clinically called opioid use disorder, involves compulsive use despite harm, loss of control, and disruption to your life. Everyone who takes methadone long enough becomes physically dependent. Not everyone becomes addicted.
The CDC uses 11 criteria to diagnose opioid use disorder, including taking opioids in larger amounts than intended, unsuccessful attempts to cut back, cravings, continued use despite social or physical problems, and withdrawal of activities you used to enjoy. A person meets the diagnosis when at least two of these criteria occur within a year. Critically, tolerance and withdrawal on their own do not count toward a diagnosis for someone taking opioids under appropriate medical supervision. This is an important carve-out: a patient on a stable methadone maintenance dose who experiences no cravings, holds a job, and uses the medication as prescribed is dependent but not addicted by clinical standards.
How Quickly Tolerance Develops
Your body begins adapting to methadone faster than most people expect. Clinical evidence of opioid tolerance can appear within just a few weeks of regular use, regardless of whether the opioid is methadone, oxycodone, or morphine. Tolerance means you need more of the drug to get the same effect, or the same dose stops working as well. This applies to both pain relief and any pleasurable sensations.
Tolerance is one reason methadone treatment programs monitor patients closely in the early weeks, adjusting the dose to find a level that controls cravings without causing sedation or euphoria. SAMHSA guidelines call for multiple clinic visits during the first two weeks of treatment specifically to ensure safe dose adjustment. Patients who are new to methadone are typically not given doses to take home until their treatment team is confident the dose is stable and the patient is managing well.
What Withdrawal Looks Like
Methadone withdrawal is real, uncomfortable, and notably longer than withdrawal from short-acting opioids. Symptoms typically begin one to three days after the last dose, which is slower than heroin or oxycodone withdrawal (which can start within hours). Symptoms generally peak around two to three days after onset and include muscle aches, nausea, sweating, anxiety, insomnia, and diarrhea.
The severity is usually less intense than withdrawal from fast-acting opioids, but the duration is significantly longer. While heroin withdrawal often resolves within a week, methadone withdrawal can stretch for several weeks. This extended timeline is a direct consequence of how slowly methadone clears the body. It’s also one of the reasons people find it difficult to stop: the prolonged discomfort creates strong motivation to keep taking the drug, which can feel like addiction even in someone who was using it appropriately.
Overdose Risk
Methadone can be fatal in overdose, particularly for people who are not opioid-tolerant. In 2024, methadone was involved in 3,229 drug overdose deaths in the United States, a rate of 0.9 per 100,000 people. For comparison, synthetic opioids other than methadone (primarily fentanyl) were involved in 47,735 deaths that same year, at a rate of 14.3 per 100,000. Methadone deaths represent a small fraction of the overall opioid crisis, but they are not negligible.
The risk is highest during the first two weeks of treatment, when the dose is still being calibrated, and when methadone is combined with other sedating substances like alcohol or benzodiazepines. People who obtain methadone outside of a treatment program face elevated risk because they lack medical oversight of their dose. The drug accumulates in the body over days, so a dose that seems manageable on day one can become dangerous by day three as levels build up.
Long-Term Effects on the Brain
Extended methadone use does appear to change brain structure and function. Brain imaging studies of patients on methadone maintenance therapy have found reductions in gray matter volume in regions involved in emotional processing, working memory, and spatial awareness. Compared to people not taking opioids, long-term methadone patients showed measurable declines in attention, information processing speed, short-term memory (both visual and verbal), and problem-solving ability.
Research has also found lower activity in dopamine transport systems in the brain’s reward centers, which may explain why some long-term patients report feeling emotionally flat or less motivated. These findings come from relatively small studies, and it can be difficult to separate the effects of methadone itself from the lasting effects of prior heroin or other opioid use. Still, the cognitive changes are consistent enough to be worth knowing about, especially for people weighing the long-term trade-offs of maintenance therapy.
The Paradox of Treating Addiction With an Addictive Drug
Methadone maintenance works not because it eliminates dependence, but because it replaces chaotic, dangerous opioid use with a stable, controlled form of dependence. A person on a steady methadone dose is physically dependent on the drug but can function, work, and avoid the cycle of intoxication and withdrawal that drives compulsive heroin or fentanyl use. The trade-off is real: you are tethered to a clinic, you will experience withdrawal if you stop, and there are cognitive costs over time.
Whether that trade-off is worth it depends on what the alternative looks like. For someone cycling through overdoses and unable to stop using fentanyl, methadone’s addictive properties are a feature, not a bug. The steady receptor activation is precisely what keeps cravings manageable. For someone considering methadone for chronic pain who has no history of opioid use, the calculus is different, and the risk of developing problematic use is something to weigh carefully.
The honest answer to “how addictive is methadone” is: very, in the pharmacological sense. It binds powerfully to opioid receptors, produces dependence within weeks, and causes prolonged withdrawal. But addiction is not just pharmacology. It is the relationship between the drug, the person, and the context. Methadone prescribed and monitored in a treatment program produces dependence without necessarily producing the destructive behavioral patterns that define addiction. Methadone used outside that structure carries risks comparable to any other potent opioid.